AUG 7, 2026 · PHASE 2 TRIAL
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ClinicalTrials.gov
This is a Phase 2 screening trial registry record with no reported results; it describes planned enrollment and procedural outcomes only, not clinical efficacy or safety data.
Reported
Planned enrollment2900
Study phasePhase 2
Primary outcome measure timeframeUp to 8 years